Comparative effectiveness and drug survival of biosimilar infliximab CPT-13 vs. reference infliximab in inflammatory bowel disease: A retrospective cohort study Lidia Serrano Díaz; Carles Iniesta Navalón; Rosa Gómez Espín; Isabel Nicolás De Prado; Enrique Bernal Morell; Lorena Rentero Redondo;

Headache in patients with inflammatory bowel disease: Migraine prevalence according to the Migraine Screening-Questionnaire (MS-Q) and headache characteristics Alicia Gonzalez-Martinez; Inés Muro; Sonia Quintas; María Chaparro; Javier P. Gisbert; Ancor Sanz-García; María José Casanova; Cristina Rubín de Célix; José Vivancos; Ana Beatriz Gago-Veiga;

Validity and reliability of the health-related questionnaire IBDQ-32 in Mexican patients with inflammatory bowel disease Mónica R. Zavala-Solares; Lucero Salazar-Salas; Jesus K. Yamamoto-Furusho;